A Phase II Clinical Trial to Determine the Efficacy of Amifostine (Ethyol) in Reducing the Severity of Oral Mucositis in Patients Receiving High Dose Intra-Arterial Cisplatin and Concurrent Twice-a-Day Radiotherapy for Stage III-IV Head and Neck Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date9/9/038/31/06

Funding

  • MedImmune Inc: $8,043.00